NATIONAL JEWISH HEALTH
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- -
- Established
- 1899-01-01
- Employees
- -
- Market Cap
- -
Measuring Omalizumab Responses Using Real-world Evidence (MORRE) Study
- Conditions
- First Posted Date
- 2021-01-26
- Last Posted Date
- 2021-06-23
- Lead Sponsor
- National Jewish Health
- Target Recruit Count
- 50
- Registration Number
- NCT04724278
- Locations
- 🇺🇸
National Jewish Health, Denver, Colorado, United States
Skin Barrier Abnormalities and Oxidative Stress Response
- Conditions
- First Posted Date
- 2020-10-28
- Last Posted Date
- 2020-10-28
- Lead Sponsor
- National Jewish Health
- Target Recruit Count
- 160
- Registration Number
- NCT04606615
- Locations
- 🇺🇸
National Jewish Health, Denver, Colorado, United States
Saracatinib in the Treatment of Idiopathic Pulmonary Fibrosis
Phase 1
Active, not recruiting
- Conditions
- Interventions
- First Posted Date
- 2020-10-22
- Last Posted Date
- 2024-11-14
- Lead Sponsor
- National Jewish Health
- Target Recruit Count
- 49
- Registration Number
- NCT04598919
- Locations
- 🇺🇸
National Jewish Health, Denver, Colorado, United States
🇺🇸Baylor University Medical Center (BUMC), Dallas, Texas, United States
🇺🇸Icahn School of Medicine at Mount Sinai, New York, New York, United States
Lung Clearance Index to Identify Scleroderma Patients at Risk for ILD
- First Posted Date
- 2020-09-01
- Last Posted Date
- 2023-03-24
- Lead Sponsor
- National Jewish Health
- Target Recruit Count
- 50
- Registration Number
- NCT04535245
- Locations
- 🇺🇸
National Jewish Health, Denver, Colorado, United States
Hand Sanitizer Effects on the Skin Barrier
- First Posted Date
- 2020-08-25
- Last Posted Date
- 2021-03-02
- Lead Sponsor
- National Jewish Health
- Target Recruit Count
- 40
- Registration Number
- NCT04525521
- Locations
- 🇺🇸
National Jewish Health, Denver, Colorado, United States
Creation of Home-based Asthma Real-World Measures With Mobile Health Study
- Conditions
- First Posted Date
- 2020-07-08
- Last Posted Date
- 2021-06-23
- Lead Sponsor
- National Jewish Health
- Target Recruit Count
- 150
- Registration Number
- NCT04462224
- Locations
- 🇺🇸
National Jewish Health, Denver, Colorado, United States
Skin Barrier Assessment in Pregnancy and at Birth
- First Posted Date
- 2020-06-24
- Last Posted Date
- 2020-09-10
- Lead Sponsor
- National Jewish Health
- Target Recruit Count
- 160
- Registration Number
- NCT04445298
- Locations
- 🇺🇸
National Jewish Health, Denver, Colorado, United States
Utility of CD64 and TLR2 Assays to Diagnose Acute Pulmonary Exacerbations in Cystic Fibrosis
Completed
- Conditions
- First Posted Date
- 2020-05-21
- Last Posted Date
- 2021-09-02
- Lead Sponsor
- National Jewish Health
- Target Recruit Count
- 150
- Registration Number
- NCT04397809
- Locations
- 🇺🇸
National Jewish Health, Denver, Colorado, United States
T Cell Memory Fuels the Innate Response in Chronic CF Lung Disease
Completed
- Conditions
- First Posted Date
- 2020-05-21
- Last Posted Date
- 2022-09-29
- Lead Sponsor
- National Jewish Health
- Target Recruit Count
- 112
- Registration Number
- NCT04397861
- Locations
- 🇺🇸
National Jewish Health, Denver, Colorado, United States
Host and Bacterial Mechanisms During Cystic Fibrosis Pulmonary Exacerbations
Active, not recruiting
- Conditions
- First Posted Date
- 2020-04-21
- Last Posted Date
- 2022-09-30
- Lead Sponsor
- National Jewish Health
- Target Recruit Count
- 100
- Registration Number
- NCT04354038
- Locations
- 🇺🇸
National Jewish Health, Denver, Colorado, United States
© Copyright 2024. All Rights Reserved by MedPath